Key Players
Competitive Landscape
Competition in crepey skin treatments divides among four business models: global beauty groups and mass body-care platforms. Skin-care specialists and digital-first brands form the other two groups, with each model carrying different claim and channel economics.
The May 2025 rhode agreement marked a move toward skin-focused acquisitions with built-in community demand. e.l.f. Beauty agreed to buy rhode for USD 1 billion that month. Hindustan Unilever completed its 90.5% Minimalist acquisition on April 21 after announcing the actives-led beauty deal in January. Portfolio expansion now depends more heavily on treatment credibility and brand trust before distribution scale converts attention into repeat skin-care purchasing.
Company developments mapped to drivers, trends and opportunities (2026-2036)
| Development | Driver | Trend | Opportunity |
|---|---|---|---|
| Beiersdorf introduced NIVEA EPICELLINE serum in August 2025. | Consumers want visible-aging claims at accessible price points. | Epigenetic concepts are moving from premium science into mass skin care. | Mass franchises can translate age-science stories into repeat daily routines. |
| Shiseido opened Beauty Park in Yokohama in January 2025. | Skin-care users increasingly expect explanation and diagnostic guidance beside products. | R&D sites are becoming consumer-facing testing and co-creation environments. | Companies can improve product education before new aging-care launches reach wider retail. |
| L'Oreal and NUS Medicine launched a multi-year longevity research partnership in August 2026. | Aging consumers are asking for care linked to healthier skin function over time. | Skin longevity is becoming a formal research field inside major beauty groups. | New biomarkers and longitudinal evidence can support differentiated treatment claims and premium programs. |
Kao Corporation and Procter & Gamble compete through barrier care and daily body treatment. Amorepacific, Coty and Estee Lauder Companies bring prestige skin care and targeted aging programs outside the three mapped developments.
Source: Future Market Insights, Crepey Skin Treatments and Skincare Market Reports, 2026-2036.
Leading companies cover mass body care and prestige treatment in major retail channels. Dermocosmetic research and functional Asian skin care broaden competition beyond digital-first discovery.
Who leads the crepey skin treatments market?
L'Oreal and Beiersdorf maintain broad skin-care platforms alongside Shiseido and Estee Lauder Companies, but no public source supports a market-share ranking.
Which suppliers have documented qualification or quality approvals?
Shiseido and Kao Corporation document Japanese quasi-drug or functional claim routes in aging-care portfolios. Other global groups maintain local safety systems, but approvals remain product-specific and cannot be applied to every line.
Which companies provide body-area and mature-skin treatment products?
Procter & Gamble and Beiersdorf document recent body-area launches in daily treatment formats. Amorepacific and Kao Corporation serve mature-skin use cases spanning neck treatment and rich moisturization.
Which suppliers serve North America and East Asia?
Shiseido and Kao Corporation serve North America and East Asia from Japan-led skin-care portfolios. L'Oreal and Beiersdorf also operate in both regions through retail and specialist channels.
Representative Company Overview
| Company | Positioning | Verified Development |
|---|---|---|
| Shiseido | Global prestige and functional aging-care group with strong Japan and Asian skin-science depth. | In September 2025, ELIXIR launched a renewed retinol wrinkle cream under Japan's quasi-drug route. |
| Kao Corporation | Japanese consumer group with SENSAI, Curél and Bioré skin-care platforms spanning prestige and sensitive care. | In September 2026, Kao launched Curél in Sweden, Norway, Denmark and Finland through KICKS and Matas. |
| Unilever | Edge-of-scope global body-care and Beauty & Wellbeing group with mass skin-care brands and actives-led acquisitions. | In August 2026, Unilever and Galaxy Surfactants signed a Partnership Growth Charter covering surfactant technology and shared capacity for Dove body-wash reformulation. |
| Procter & Gamble | Global mass skin and personal-care group with Olay as the main visible-aging and body-treatment platform. | In August 2026, Olay launched the revamped Repair Serum Body Wash collection and Enrich Boosting Body Oil. |
| Amorepacific | Korean beauty group with premium and high-efficacy skin-care brands including IOPE and AP Beauty. | In August 2025, AP Beauty launched four M.D. line products including a new serum for intensive aging care. |
| L'Oreal | Global beauty group spanning consumer, luxe and dermatological skin care with deep aging-science research. | In March 2025, L'Oreal announced a research partnership with Tru Diagnostic to study epigenomic markers linked to beauty and longevity. |
| Coty | Global beauty company with selective skin-care exposure through Lancaster, Philosophy and Orveda alongside broader prestige beauty. | In March 2025, Coty completed the sale of its 20% stake in SKKN by Kim to SKIMS and ended its partnership with the skincare brand. |
| e.l.f. Beauty | Digital-first beauty group expanding from mass cosmetics into skin-focused prestige through rhode and Naturium. | In September 2026, rhode began its Sephora retail expansion in Europe after its 2025 North American and UK rollout. |
| Beiersdorf | Global skin-care group with NIVEA and Eucerin spanning mass body care and dermatological treatment. | In December 2025, Beiersdorf launched Eucerin in Japan with the HARI FILLER anti-aging care series. |
| Estee Lauder Companies | Global prestige beauty group with multiple skin-care brands and dedicated longevity research programs. | In May 2025, Estée Lauder opened its first Skin Longevity Institute in the Americas at Hacienda AltaGracia in Costa Rica. |
Research Methodology
The companies mapped here illustrate the market structure rather than an exhaustive ranking. Inclusion requires current, verifiable evidence that a company supplies topical skin-care treatments addressing visible aging, body dryness, texture or firmness within the defined crepey-skin treatment scope. Evidence comes from regulatory approvals, third-party certifications, company announcements, product documentation, and public filings. Capabilities are attributed to the stated skin-care brand, treatment line or research platform rather than generalised across broader corporate portfolios. Market-share estimates remain proprietary FMI assessments for the forecast period.
